Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

NCT03007290 — Not applicable, Completed, 15 participants, Seoul National University Hospital

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT03007290
Status	Completed
Phase	Not applicable
Study type	Interventional; na, single group, masking: none, health services research
Enrollment	15 (Actual)
Sponsor	Seoul National University Hospital (Other)
Conditions	Multidrug-resistant Gram-negative Bacteria Infection
Interventions	Therapeutic drug monitoring (Other)
Dates	start 2016-01-01, primary completion 2017-12-01, completion 2017-12-01, first posted 2017-01-02, last updated 2018-04-18
Locations	1 site in South Korea

-Summary

Clinical usefulness of therapeutic drug monitoring of colistin in patients treated with colistin

Expand all sections · Collapse all

+Arms and interventions

Arm	Type	Interventions	Description
Treatment group	Experimental	Other: Therapeutic drug monitoring	Group with therapeutic drug monitoring

Therapeutic drug monitoring (Other): Therapeutic drug monitoring for colistin

+Outcome measures

Primary outcomes

AKI [Through study completion, an average of 1 month]: Emergence rate of acute kidney injury

Secondary outcomes

Death [Through study completion, an average of 1 month]: Death rate
Negative conversion rate [Through study completion, an average of 1 month]: Culture-negative conversion rate Treatment success Treatment success

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Age over 18 years old.
* Those who receive colistin therapy for the treatment of multi-drug resistant gram negative bacteria infection.

Exclusion Criteria:

* Those who received colistin therapy less than 48 hours
* Those who received colistin therapy through the bronchus

+Locations (1)

Facility	City	Country	Status
Seoul National University Bundang Hospital	Seongnam	South Korea

My Notes

Public

To Read Reading Read